Director, US Scientific Marketing – Melanoma

remote · country director seen live 16h ago

About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time

Apply on Iovance Biotherapeutics's site

This link goes straight to the employer's greenhouse page. Posted 45 days ago.We last confirmed it was open 16h ago.